HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £38,170 | £101,094 | -£360,386 | -£167,041 |
| Dep. & Amort. | £12,341 | £8,207 | £8,664 | £7,190 |
| Deferred Tax | £0 | £607 | £0 | -£115,137 |
| Stock-Based Comp. | £21,609 | £36,600 | £30,586 | £41,990 |
| Change in WC | -£62,169 | £71,146 | £58,704 | £32,458 |
| Other Non-Cash | -£9,454 | £1,604 | -£6,167 | -£3,683 |
| Operating Cash Flow | £497 | £219,258 | -£268,599 | -£204,223 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£17,933 | -£32,612 | -£36,664 | -£16,756 |
| Net Acquisitions | £0 | -£2,990 | £324 | £159,118 |
| Inv. Purchases | -£1,848,808 | -£1,627,875 | -£1,202,013 | -£1,370,976 |
| Inv. Sales/Matur. | £1,769,403 | £1,342,846 | £1,518,453 | £921,364 |
| Other Inv. Act. | £1,278 | £29,495 | £16,488 | £930 |
| Investing Cash Flow | -£96,060 | -£291,136 | £296,588 | -£306,320 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £5,607 | £61,705 | -£9,170 | -£579 |
| Stock Issued | £790 | £5,094 | £174 | £717,319 |
| Stock Repurch. | -£36,064 | -£9,071 | -£48,084 | -£27,309 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1,000 | -£9,068 | -£25,683 | -£39,403 |
| Financing Cash Flow | -£30,667 | £48,660 | -£82,763 | £650,028 |
| Forex Effect | -£3,401 | -£6,471 | -£9,490 | £2,427 |
| Net Chg. in Cash | -£129,631 | -£29,689 | -£64,264 | £141,912 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £283,589 | £313,278 | £377,542 | £235,630 |
| End Cash | £153,958 | £283,589 | £313,278 | £377,542 |
| Free Cash Flow | -£17,436 | £186,646 | -£305,263 | -£220,979 |